|Bid||255.00 x 1200|
|Ask||255.99 x 1000|
|Day's Range||251.39 - 255.68|
|52 Week Range||177.93 - 398.88|
|Beta (3Y Monthly)||2.59|
|PE Ratio (TTM)||51.82|
|Earnings Date||Apr 24, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||271.60|
Forecasts of S&P 500 profits in 2019 are trending sharply downwards, but Goldman Sachs says that these stocks can swim against the tide.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! In December 2018, Align Technology, Inc. (NASDAQ:ALGN)Read More...
SAN JOSE, Calif., Feb. 11, 2019 -- Align Technology, Inc. (NASDAQ: ALGN) today announced that Raj Pudipeddi has joined the Company as senior vice president and CMO reporting to.
Medical device stocks remain supported by favorable conditions that should see sales grow. Watch these three stocks for a 52-week breakout.
These baskets of stocks from Goldman Sachs have posted YTD 2019 gains nearly double that of the S&P 500. This is the first of 2 stories on them.
What started as a touch-and-go day certainly didn't end as one. With some dovish words accompanying the Federal Reserve's decision to stand pat with interest rates, the S&P 500 rallied 1.55% to the highest close since early December. Advanced Micro Devices (NASDAQ:AMD) led the way, gaining almost 20% on a surprisingly encouraging 2019 sales outlook. Boeing (NYSE:BA) had a strong showing too though, rallying more than 6% after posting a fourth-quarter earnings beat driven by record-breaking sales of aircraft. Not every name was swept up in the broad market's bullish swing, however. AT&T (NYSE:T) fell 4.3% after reporting lackluster quarterly results. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome to earnings seasons. Headed into Thursday's trading, it's the stock charts of Mcdonald's (NYSE:MCD), Align Technology (NASDAQ:ALGN) and Facebook (NASDAQ:FB) that look like the best potential opportunities, mostly because they're not dishing out the wild swings that turn trades into coin tosses. ### Facebook (FB) In the middle of this month, Facebook shares were toying with a break above a technical ceiling around $146.30. That ended up happening, the very next day in fact, although another resistance line quickly stepped in to once again bar the rally effort. * 10 Stocks to Sell in February Thanks to the pre-earnings rally, though, bolstered by the post-close gains in response to impressive fourth quarter numbers, FB stock has broken above a major short-term resistance level and widened the distance between it and the ceiling it smashed five weeks ago. Click to Enlarge • The 100-day moving average line, plotted in gray, was the resistance level causing trouble of late, but Facebook pushed above it yesterday. • Though it didn't break to new multiweek highs during regular market hours, shares were trading around $162 in after-hours action. That's well above the last of the remaining near-term ceilings around $151.50, plotted with a yellow dashed line. • The weekly chart shows recent bullishness is actually just an extension of the rebound that took shape late last year and in the first week of this year. The falling resistance line that had guided it lower since the middle of last year was cleared, and for the most part the buyers didn't look back. ### Mcdonald's (MCD) With just a quick glance, the 0.22% setback Mcdonald's shares suffered on Wednesday was nothing. Although the market was up and MCD wasn't, shares of the restaurant giant have been strong performers of late. Things happen. A closer examination of the bar Mcdonald's shares left behind yesterday, however, is merited, as it suggests a major shift in how investors now see the stock. Click to Enlarge • The deep low and wild high were clearly, visibly unusual, but it's also a red flag. Wild intraday swings often indicate a rethinking from investors. The volume spike suggests the same. • Zooming out to the weekly chart we gain some perspective on what's taking shape here. MCD is still overbought from the November surge. • Although the bar -- called a doji -- hints of a pivot, it's not perfectly clear which direction the pivot is pointed. If it's lower, that will be confirmed by a move back below the blue 20-day moving average line and the purple 50-day moving average line in the very near future. ### Align Technology (ALGN) Finally, yesterday's 4.9% jump from Align Technology shares was well above average, but hardly jaw-dropping. The stock is still much closer to recently-hit 52-week lows than it is 52-week highs. But, the shape and placement of yesterday's bar from ALGN is telling in and of itself. Wednesday's action looks like it could have been the much-needed jolt out of a rut and back into a recovery. Click to Enlarge • The initial reaction to Align's fourth-quarter numbers was a bearish open, below Tuesday's close. But, by the time the closing bell rang, ALGN was well above the prior day's high. This "engulfing" bar indicates a sweeping change in sentiment. • Bolstering the bullish argument is the massive volume behind the decent gain. Many traders have been waiting in the wings to become buyers. • Beckoning the stock higher from here is the gap that was left behind with October's plunge. The upper boundary of that gap is around $289.50, though there's a potential ceiling at $235.60 that needs to be cleared first. As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can follow him on Twitter, at @jbrumley. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Smart Money Stocks to Buy for the Rest of the Year * 10 Best Consumer Stocks to Buy in 2019 * 10 Triple-A Stocks to Buy in February Compare Brokers The post 3 Big Stock Charts for Thursday: Align Technology, Facebook and Mcdonald's appeared first on InvestorPlace.
Staar Surgical Co. (STAA) has a proprietary product that, in my opinion, is newer and better than Lasik in the growing refractive procedure market. While I am not a growth investor, Staar Surgical looks like a rare, low-risk growth case to me. Implantable collamer lenses are an alternative way to permanently correct your vision.
Align Technology (NASDAQ:ALGN) dropped sharply at the open despite beating earnings and revenue estimates. The San Jose-based manufacturer of scanners and aligners used in orthodontics reported double-digit revenue and earnings increases. However, Align stock initially fell on weakened pricing for Invisalign. Still, traders appeared to interpret the drop as a knee-jerk reaction. By the middle of the day, the stock erased all of the losses and had turned positive, closing up about 2.6%. Both the quick recovery and the growth of its popular Invisalign orthodontic product show that Align stock is a buy on any pullback. ### ALGN Stock Is Driven by Robust Growth… And Hesitation For the fourth quarter, ALGN reported GAAP EPS of $1.20 per share. Wall Street had expected $1.14 per share. The company earned only 13 cents per share in the same quarter last year. Revenues of $534.02 million also came in $19.4 million higher than expectations. They also increased 26.7% from year-ago levels when the company reported quarterly revenue of $421.3 million. InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 5 Top Consumer Stocks for 2019 -- According to Wells Fargo The stock might have experienced a carryover of some of the emotion from the previous earnings report. Like many tech stocks, ALGN stock peaked in early October. It then began to plunge. That culminated in a one-day drop of about 20% following its third-quarter earnings report. Align stock has remained in a range since. However, the initial drop following Q4 earnings may have served as a catalyst for an upward move. Given the Q4 numbers, it makes little sense that Align stock plunged at the market open. Yes, the average selling prices on its popular Invisalign clear aligners fell on a year-over-year basis. Invisalign differentiates Align from firms such as Dentsply Sirona (NASDAQ:XRAY) and Danaher (NYSE:DHR) -- who focus more on consumables and equipment. For this reason, Invisalign-related news often drives the equity. Still, with overall profit growth much higher, that fact seems less relevant. ### Earnings May Have Become a Catalyst for Align Stock Traders appear to have come to the same conclusion. Align stock began the trading day by falling almost 7% from the previous close. However, by the middle of the day, the stock was trading above levels of the prior day. I think the early buyers made the correct call. ALGN's forward P/E ratio stands at around 40. Diluted earnings also increased by 73.9% for the year to $4.92 per share. The current 2019 earnings forecast of $5.83 per share would take profit growth down to 18.5%. Still, considering those growth levels, the P/E does not appear elevated. Admittedly, valuations had probably moved ahead of themselves following the increases ALGN saw for most of 2018. Many key patents on Invisalign expired at the end of 2017. When traders saw profit increases continuing without the Invisalign patent protection, they continued to bid up the stock price for 2018. This set up for the fall that began in October. As a result, Align stock has fallen by about 45% from its 52-week high. However, ALGN stock now trades at a much lower multiple. With its years-long track record of double-digit earnings increases expected to continue, investors should treat any moment of panic as a buying opportunity. ### The Bottom Line on Align Stock In an ironic twist, signs of softness in pricing may have become the catalyst that Align stock needs to resume growth. ALGN handily beat earnings and revenue expectations in its Q4 report. However, the stock initially sold off as reports of lower pricing for its Invisalign orthodontic product weighed on the equity. * 10 Stocks to Sell in February Still, as the trading day went on, buyers erased that loss and bid the ALGN stock price above yesterday's closing levels. Traders likely saw an opportunity as the company growth levels remain on track. If the move higher continues, the bright smiles that Align makes possible will go well beyond the orthodontic practices it serves. As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Smart Money Stocks to Buy for the Rest of the Year * 10 Best Consumer Stocks to Buy in 2019 * 10 Triple-A Stocks to Buy in February Compare Brokers The post Earnings Report Brings Brighter Smiles to Align Stock Investors appeared first on InvestorPlace.
The orthodontic-device maker posts record-high revenue. But it expects growth to slow considerably in the first quarter of 2019.
Check out the companies making headlines after the bell:Apple AAPL shares jumped more than 6 percent after the bell following an earnings beat on Tuesday. The company earned $84.31 billion in revenue, which beat estimates of $83.
Market action was mixed on Tuesday and market players awaited earnings from Apple and the next Federal Reserve interest rate decision. Breadth was slightly positive but big cap technology stocks were weak which reflected some nervousness over the Apple report.
The San Jose, California-based company said it had profit of $1.20 per share. The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was ...
2018 revenues up 33.5% to a record $2.0 billion2018 Invisalign volume of 1.2 million cases up 31.9% and iTero scanner volume up 77.2%2018 operating margin of 23.7% and diluted.
Today we'll evaluate Align Technology, Inc. (NASDAQ:ALGN) to determine whether it could have potential as an investment idea. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will Read More...
Align Technology (ALGN) is likely to gain from strength in Invisalign space as well as Scanner and Service business in fourth-quarter 2018.